Untitled Document
www.expresspharmaonline.com FORTNIGHTLY INSIGHT FOR PHARMA PROFESSIONALS
1-15 March 2006  
Untitled Document
Sections

Market
Management
Research
Pharma Life

Services
Subscribe/Renew
Archives
Contact Us
Events
Pharma Excellence Awards
Network Sites
Express Computer
Network Magazine India
Express Hospitality
Express TravelWorld
feBusiness Traveller
Exp. Healthcare Mgmt.
Express Textile
Group Sites
ExpressIndia
Indian Express
Financial Express

Partner Assns.

    RESEARCH - Expertise for Drug Development
 

Fever is Rising
125 years after the discovery of the malaria parasite, an ideal drug or vaccine for malaria has been elusive so far. Efforts have not been successful so far because scientists don't have knowledge about the components of the natural immune response to malaria that provide protection against the dreaded disease. Sapna Dogra takes stock of the current state of affairs

Bharat biotech announces Rotavirus vaccine
The Indian Rotavirus Vaccine Development Project (RVDP), announced encouraging results from a recent Phase I clinical trial of two live, natural reassortant, candidate rotavirus vaccines, 116E and I321, conducted in New Delhi, India.

RNA mediated inhibition
Dr Anirban Sadhu explores the exciting field of research in RNA interference

Reverse Acquisition - A new trend among CROs
Mergers and acquisitions were common in the pharma industry. Now the CROs are following suit. Murtuza Bughediwala and Arun Bhatt take a look at reverse acquisitions in the CRO industry


Untitled Document
Untitled Document
© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.